Скачать или смотреть Utilising Repurposed Drugs and Personalization in Cancer Research

Dr. Padman Vamadevan and Astron’s Chief Science Officer, Travis Christofferson, discuss how Astron goes beyond traditional oncology by analyzing overlooked subgroup data in published studies.

Travis explains how trials on repurposed drugs like Celecoxib and Metformin reveal major survival benefits in patients with specific mutations — data often missed in standard oncology practice. He also highlights simple, evidence-based factors such as fiber intake and vitamin D levels that can dramatically influence immunotherapy outcomes. This segment shows how Astron turns hidden insights into practical, personalized care recommendations.

Want an Astron Research Report in the US?
Start here with Meakin Metabolic to get your order - https://meakinmetaboliccare.com/astro...

What we cover
• How to coordinate molecular testing and when to use existing results
• What’s inside an Astron Research Report and how evidence is weighed
• Turning findings into a practical treatment roadmap with a prescribing clinician
• Insurance and affordability pathways for testing, plus common FAQs

Quick start (3 steps)
1) Arrange molecular testing with an oncologist
2) Use that to order and receive your Astron Research Report (evidence-weighted options)
3) Translate the report into a safe plan with your clinician

Panel & resources
Dr. Charles “Chuck” Meakin — Meakin Metabolic Care (Founder)
• For US Astron Research Reports & consults: https://meakinmetaboliccare.com/astro...
• Practice info: https://meakinmetaboliccare.com/
Dr. Padman Vamadevan and Travis Christofferson — Astron Health
• Astron Health website & reports: https://www.astron.health/
• Contact: [email protected]
Paityn Thorne — HealNavigator (Head of Patient Care)
• Learn more: https://healnavigator.com/